CS-121 APOC3 Base Editing in FCS

Clinical trial NCT07176923 · RECRUITING

Trial details

NCT number: NCT07176923
Sponsor: CorrectSequence Therapeutics Co., Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Familial Chylomicronemia Syndrome (FCS)

Start date: 2025-10-15
Primary completion: 2026-12-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.